Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
about
ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancersCombinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatinThe Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria.Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.Phytochemicals: a multitargeted approach to gynecologic cancer therapy.Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cellsDown-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Stromal Expression of Fibroblast Activation Protein Alpha (FAP) Predicts Platinum Resistance and Shorter Recurrence in patients with Epithelial Ovarian Cancer.Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagyA critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthDual Targeting of mTOR Activity with Torin2 Potentiates Anticancer Effects of Cisplatin in Epithelial Ovarian CancerPrognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cellsRY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.Suppression of human epidermal growth factor receptor 2 via interference increases the chemosensitivity of ovarian carcinomaEts-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer.Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells.Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer.The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway.Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer.Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin.Macranthoside B Induces Apoptosis and Autophagy Via Reactive Oxygen Species Accumulation in Human Ovarian Cancer A2780 Cells.Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer.20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways.Epigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells.Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy.Role of wild-type p53-induced phosphatase 1 in cancerCorosolic acid enhances the antitumor effects of chemotherapy on epithelial ovarian cancer by inhibiting signal transducer and activator of transcription 3 signalingHeparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway.The miR-200 family in ovarian cancer.Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.Molecular mechanisms of drug resistance in ovarian cancer.Phosphorylation of caspase-9 at Thr125 directs paclitaxel resistance in ovarian cancer.
P2860
Q28271111-EF24CD59-8D1E-4D10-BCCC-378D87C004CFQ28537820-7C2CA01E-ADE2-4DA6-90AD-11DA10C83DFBQ30313205-DDFDCBA3-7688-43F9-A09D-D05839E0EB2AQ30668565-C231FC06-7544-420A-9D04-E5B0CDEA5A3AQ33845577-F2789F8F-7CC6-4D46-AE17-851DEE2D8056Q33908881-E51A12D8-5B8A-48AE-AD93-5CA251EC76E9Q34424411-D21DBD53-9462-450B-9764-5D515315E04FQ34468400-A9B30080-7C94-420E-A821-EE3EA3289AFBQ35089472-0457FC40-B79D-457C-9428-26261981F0F8Q35109273-3E67FC7C-76E1-4D13-8178-5A36353336EAQ35666119-0B9404AA-9AF0-4A89-845C-D440781C58AAQ35852880-ADC3A1DA-FE95-4875-BB18-8C67BEDB82A5Q35936614-A03A5AA0-B159-42D1-B392-B0ACD008E32BQ36011433-F1BC727A-24E8-4468-8DCF-1E17B4E997A7Q36167088-DA298FEE-F8DE-4F0F-A275-78E00786EA1DQ36182381-72627EE1-E63A-4EF3-BFB1-6C6704BDB8F7Q36214686-8126B212-4F74-42CD-81A6-58BC4DA9826DQ36265840-4F421BE6-2B3E-4C24-BE95-A0926E17305FQ36413165-AA1CD4E7-A2F9-46B5-9174-B3F585EE38BEQ36825008-5CB4C54C-F1F6-452A-AB7B-0C5213072D26Q37348076-3199326E-62D4-4CEA-B96C-6CE82C4FABF9Q37392887-4817ED80-FCE4-40C1-BA91-092AEAFFDF20Q37582011-C1165954-86DA-4FCD-B39E-20AAA3B54AA4Q37651305-8B933BAE-5655-4EE4-809D-7EA8B0D6732DQ37652592-718B5F2E-AE74-48F0-88BA-9D7861801B9CQ38295735-1C268E9A-FB47-45D2-B253-B06AF64D798DQ38687770-C54685EA-FAFC-42E0-9857-6E1852020937Q38788954-AD3CACBD-B2A5-477B-BB8A-9F07B8905FF6Q38829925-A4BDD11E-3635-442E-90A4-2100C17222E3Q38962078-9FD16309-A7A0-4060-9B85-E35C8174904BQ39022355-C532D0D2-41EB-4592-872E-5566953EDF7FQ41615733-011C00D2-39B8-4E12-A2FA-1EF418C17AAAQ41676837-290C4FE3-B3BD-448E-8881-4080C337370CQ41948802-D909AF50-33A4-4F57-9680-6FAF70C8F9E0Q42366558-3089C92A-66CA-49F2-AE3B-2DB501D5039FQ42371676-D91F7321-4E78-41E0-84A7-0744931ECB69Q42378299-886ECDA4-5439-4D1E-8CEA-6BE33BA03FA6Q46799064-2832C2B3-3191-4006-8859-72459085567FQ48274587-9B34E84F-D685-47FB-B4FD-3BBB1C8CFF97Q48507362-098C0DCF-6FE2-4CA6-B3E1-5C21F499907E
P2860
Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular determinants of ovar ...... insights into an old conundrum
@ast
Molecular determinants of ovar ...... insights into an old conundrum
@en
type
label
Molecular determinants of ovar ...... insights into an old conundrum
@ast
Molecular determinants of ovar ...... insights into an old conundrum
@en
prefLabel
Molecular determinants of ovar ...... insights into an old conundrum
@ast
Molecular determinants of ovar ...... insights into an old conundrum
@en
P2093
P2860
P1476
Molecular determinants of ovar ...... insights into an old conundrum
@en
P2093
Ahmed Y Ali
Hyong Joo Lee
Jeong-Yong Suh
Ji Young Kim
Lee Farrand
Sanguine Byun
P2860
P356
10.1111/J.1749-6632.2012.06734.X
P407
P5008
P577
2012-10-01T00:00:00Z